Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Naltrexone And Bupropion

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 92

NCT04599478

ArmPopulationDoseWeeksEstimandWeight change
Behavioral Weight Loss (BWL) + Naltrexone and Bupropion (NB) medicationObesity or overweightn/r16n/rn/r
BWL + PlaceboObesity or overweightn/r16n/rn/r
NB medicationObesity or overweightn/r16n/rn/r
PlaceboObesity or overweightn/r16n/rn/r